Shitara, K., Özgüroğlu, M., Bang, Y. J., Di Bartolomeo, M., Mandalà, M., Ryu, M. H., Fornaro, L., Olesiński, T., Caglevic, C., Chung, H., Muro, K., Gökkurt, E., Mansoor, W., McDermott, R., Schacham-Shmueli, E., Chen, X., Kang, S. P., Mayo, C., Ohtsu, A., & Fuchs, C. (n.d.). lBA-005KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095501770.0x00002d